(Q85016021)

English

Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF

scientific article published on 09 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Michael J Townsend

10

object named as

Michael J. Townsend

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833179

11 July 2024

author name string

Donnie Delarosa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jason Chinn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Fojan Zamanian

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Anan Chuntharapai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

James Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Phil Hass

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Nathan Wei

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jianyong Wang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Laura E. DeForge

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833179

11 July 2024

Kelly M. Loyet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833179

11 July 2024

Wai Lee T. Wong

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833179

11 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20833179

11 July 2024

publication date

9 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0022175910002589?httpAccept=text/xml

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

https://api.elsevier.com/content/article/PII:S0022175910002589?httpAccept=text/plain

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Journal of Immunological Methods

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

362

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

70-81

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases

1

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

2

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

The war on heterophilic antibody interference

4

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Human heterophilic antibodies display specificity for murine IgG subclasses

5

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

7

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses

8

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies

10

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Increased expression of interleukin 17 in inflammatory bowel disease

11

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Evidence for presence of IgG4 anti-immunoglobulin autoantibodies in all human beings

12

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs

13

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

14

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding

15

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

A radical approach is needed to eliminate interference from endogenous antibodies in immunoassays

16

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis

17

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

18

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Interleukin-17 family members and inflammation

20

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer

22

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Fit-for-purpose method development and validation for successful biomarker measurement.

23

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma

24

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays

25

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

The role of IL-17 and family members in the pathogenesis of arthritis

26

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Cytokine profile of Armenian patients with Familial Mediterranean fever

27

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Systemic and pulmonary effector cell function after injury

28

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

The biological functions of T helper 17 cell effector cytokines in inflammation

29

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

"Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy.

30

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen

31

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay

32

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies.

39

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus

40

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

41

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells

42

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex

43

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Performance of the enhanced Abbott AxSYM cardiac troponin I reagent in patients with heterophilic antibodies

44

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis

45

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

46

1 reference

10.1016/J.JIM.2010.09.004

https://api.crossref.org/works/10.1016/J.JIM.2010.09.004

11 July 2024

Identifiers

10.1016/J.JIM.2010.09.004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20833179%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85016021&oldid=2201096992"